Expert Opinion on Investigational Drugs logo Informa Healthcare logo

Publisher: Informa Healthcare

Volume 9, Number 4, April 2000
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Reviews

Therapeutic developments in multiple sclerosis
pp. 655-670(16)
Author: Goodin D.S.

Anti-inflammatory drugs: a hope for Alzheimer’s disease?
pp. 671-683(13)
Authors: Hüll M.; Lieb K.; Fiebich B.L.

Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease
pp. 685-694(10)
Author: Granholm A-C.

Neuroprotection in cerebrovascular disease
pp. 695-711(17)
Author: Jain K.K.

Current status of viral gene therapy for brain tumours
pp. 713-726(14)
Author: Gupta N.

Immunotherapeutic approaches to paraneoplastic neurological disorders
pp. 727-733(7)
Author: Blaes F.

Neurokinin receptor antagonists
pp. 735-746(12)
Authors: Leroy V.; Mauser P.; Gao Z.; Peet N.P.

Apoptosis modulators in the therapy of neurodegenerative diseases
pp. 747-764(18)
Authors: Deigner H-P.; Haberkorn U.; Kinscherf R.

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease
pp. 765-777(13)
Author: Yamada K.A.

Mechanisms of action and resistance to tubulin-binding agents
pp. 779-788(10)
Author: Dumontet C.

Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury
pp. 789-805(17)
Author: Behrend M.

Influence of photodynamic therapy on immunological aspects of disease - an update
pp. 807-817(11)
Authors: Hunt D.W.; Chan A.H.

Miscellany

Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic
pp. 819-828(10)
Authors: Daniel D.G.; Copeland L.F.

An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development
pp. 829-840(12)
Author: Jain K.K.

Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia
pp. 841-858(18)
Author: Heydorn W.E.

Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage
pp. 859-870(12)
Author: Jain K.K.

Remacemide: current status and clinical applications
pp. 871-833(-37)
Authors: Schachter S.C.; Tarsy D.

Pharmacology and clinical experience with repaglinide
pp. 885-898(14)
Authors: Massi-Benedetti M.; Damsbo P.

Ongoing trials in Alzheimer’s disease
pp. 899-915(17)
Authors: Sramek J.J.; Cutler N.R.

Ongoing trials in HIV protease inhibitors
pp. 917-928(12)
Author: Tavel J.A.

Angiogenesis - Research Frontiers. A Basic Science Conference of the New York Academy of Medicine
pp. 929-935(7)
Authors: Sepp-Lorenzino L.; Pan B-S.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A